Approval · Notice of Compliance 12748 · 2011
SUBUTEX: Notice of Compliance 12748
Issued October 28, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12748
- Date
- October 28, 2011
- Company
- Rb Pharmaceuticals LimitedSlough, Berkshire, United Kingdom
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer Name Change
- Therapeutic class
- Opiate Agonist-Antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SUBUTEX | 02242962 | — |
| SUBUTEX | 02242963 | — |
| SUBUTEX | 02242964 | — |
Medicinal ingredients
- BUPRENORPHINE HYDROCHLORIDE 0.4 MG per TAB
- BUPRENORPHINE HYDROCHLORIDE 2 MG per TAB
- BUPRENORPHINE HYDROCHLORIDE 8 MG per TAB